Designed to drive innovation and support companies of all sizes on the discovery journey, this platform offers industry early access to one of the world’s most diverse, and completely novel Natural Product Libraries, developed by the Liverpool School of Tropical Medicine (LSTM).
This vast, untapped pool of thousands of environmental bacterial, and fungal isolates has the potential to shape the next generation of transformative novel antimicrobial products and therapies.
The library is designed in a modular format to improve usability, increase efficiency and access, and bring down cost. This enables a targeted approach, where specific isolate groups can be screened quickly and cost-efficiently. World-class end-to-end expertise and after-care from the expert team at LSTM ensures companies are supported at every stage of the discovery journey.
Expert antimicrobial product development support, validation, and consultancy is also available to industry partners at the early stage of the product development journey.
For more information or to learn how your business can engage with this platform.
Reader, Antimicrobial Chemotherapy and Resistance, Liverpool School of Tropical Medicine
Adam Roberts is a Reader and AMR lead at the Liverpool School of Tropical Medicine. Adam has been investigating the fundamental mechanisms of transferable AMR for more than 20 years and, since arriving at Liverpool School of Tropical Medicine in 2017, has focussed on translational aspects of AMR and early-stage drug discovery and development.